Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
- PMID: 11509958
- DOI: 10.1038/sj.gt.3301514
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
Abstract
Adeno-associated virus (AAV) vectors package single-stranded genomes and require host-cell synthesis of the complementary strand for transduction. However, when the genome is half wild-type size, AAV can package either two copies, or dimeric inverted repeat DNA molecules. Dimeric, or self-complementary molecules (scAAV) should spontaneously reanneal, alleviating the requirement for host-cell DNA synthesis. We generated and characterized scAAV vectors in order to bypass the rate-limiting step of second-strand synthesis. In vitro, scAAV vectors were five- to 140-fold more efficient transducing agents than conventional rAAV, with a 5.9:1 particle to transducing unit ratio. This efficiency is neither greatly increased by co-infection with Ad, nor inhibited by hydroxyurea, demonstrating that transduction is independent of DNA synthesis. In vivo, scAAV expressing erythropoietin resulted in rapid and higher levels of hematocrit than a conventional single-stranded vector. These novel scAAV vectors represent a biochemical intermediate in rAAV transduction and should provide new insights into the biology of vector transduction.
Similar articles
-
[Trends in development of self-complementary adeno-associated virus vector].Sheng Wu Gong Cheng Xue Bao. 2009 May;25(5):658-64. Sheng Wu Gong Cheng Xue Bao. 2009. PMID: 19670632 Review. Chinese.
-
Self-complementary AAV vectors; advances and applications.Mol Ther. 2008 Oct;16(10):1648-56. doi: 10.1038/mt.2008.171. Epub 2008 Aug 5. Mol Ther. 2008. PMID: 18682697 Review.
-
Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.Gene Ther. 2008 Sep;15(18):1287-93. doi: 10.1038/gt.2008.89. Epub 2008 May 22. Gene Ther. 2008. PMID: 18496572
-
Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.Mol Ther. 2004 Nov;10(5):950-7. doi: 10.1016/j.ymthe.2004.07.018. Mol Ther. 2004. PMID: 15509512
-
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.Gene Ther. 2003 Dec;10(26):2112-8. doi: 10.1038/sj.gt.3302134. Gene Ther. 2003. PMID: 14625565
Cited by
-
Enhanced transgene expression from single-stranded AAV vectors in human cells in vitro and in murine hepatocytes in vivo.Mol Ther Nucleic Acids. 2024 Apr 23;35(2):102196. doi: 10.1016/j.omtn.2024.102196. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38766527 Free PMC article.
-
Subretinal AAV delivery of RNAi-therapeutics targeting VEGFA reduces choroidal neovascularization in a large animal model.Mol Ther Methods Clin Dev. 2024 Mar 22;32(2):101242. doi: 10.1016/j.omtm.2024.101242. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38605811 Free PMC article.
-
Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes.Clin Transl Med. 2024 Mar;14(3):e1607. doi: 10.1002/ctm2.1607. Clin Transl Med. 2024. PMID: 38488469 Free PMC article. Review.
-
A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR.Mol Ther Methods Clin Dev. 2024 Feb 3;32(1):101206. doi: 10.1016/j.omtm.2024.101206. eCollection 2024 Mar 14. Mol Ther Methods Clin Dev. 2024. PMID: 38390555 Free PMC article.
-
Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy.Int J Mol Sci. 2024 Jan 17;25(2):1113. doi: 10.3390/ijms25021113. Int J Mol Sci. 2024. PMID: 38256186 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources